Abstract:Purpose: Candida tropicalis (C. tropicalis) has emerged as an important fungal pathogen due to its increasing resistance to conventional antifungal agents, especially fluconazole (FLC). Pseudolaric acid B (PAB), a herbal-originated diterpene acid from Pseudolarix kaempferi Gordon, has been reported to possess inhibitory activity against fungus. The present study aims to investigate the antifungal effect of PAB alone and in combination with FLC on planktonic and biofilm cells of C. tropicalis.Methods: The antifungal activity of PAB against planktonic isolates was evaluated alone and in combination with FLC using the chequerboard microdilution method and growth curve assay. The anti-biofilm effects were quantified by tetrazolium (XTT) reduction assay, which were further confirmed by scanning electron microscopy (SEM) and fluorescent microscope to observe morphological changes of biofilm treated with PAB and FLC.Results: It was revealed that PAB alone exhibited similar inhibitory activity against FLC-resistant and FLC-susceptible strains with median MIC ranging from 8 to 16 mu g/mL. When administered in combination, synergism was observed in all (13/13) FLC-resistant and (2/9) FLC-susceptible strains with FICI ranging from 0.070 to 0.375. Moreover, the concomitant use of PAB and FLC exhibited a strong dose-dependent synergistic inhibitory effect on the early and mature biofilm, eliminating more than 80% biofilm formation. SEM found that PAB, different from azoles, could significantly inhibit spore germination and destroy the cell integrity causing cell deformation, swelling, collapse and outer membrane perforation.Conclusion: PAB was highly active against FLC-resistant isolates and biofilm of C. tropicalis, particularly when combined with FLC. These findings suggest that PAB may have potential as a novel antifungal agent with different targets from azole drugs.

In Vitro Activities of Retigeric Acid B Alone and in Combination with Azole Antifungal Agents Against Candida Albicans

In Vitro Interactions of Micafungin with Amphotericin B, Itraconazole or Fluconazole Against the Pathogenic Phase of Penicillium Marneffei.

In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii

In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales

In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans: Synergy of PAB and FLC against Candida albicans

Combination Antifungal Activity of Ethanol Extracts from Rubus Idaeus and Antifungal Azoles

In vitro activity of terbinafine in combinations with other antifungi drugs against clinical pathogenic fungi of vulvovaginal candidiasis

Antifungal Activity and Potential Mechanism of 6,7, 4′-O-Triacetylscutellarein Combined With Fluconazole Against Drug-Resistant C. albicans

Synergistic Effect Of Pseudolaric Acid B With Fluconazole Against Resistant Isolates And Biofilm Of Candida Tropicalis

Potent Antifungal Activity of Pure Compounds from Traditional Chinese Medicine Extracts Against Six Oral Candida Species and the Synergy with Fluconazole Against Azole-Resistant Candida Albicans

In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles

In vitro activities of nine antifungal agents against rare pathogenic fungi.

Pseudolaric Acid A: A Promising Antifungal Agent Against Prevalent Non- albicans Candida Species

Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo

In vitro Activity of Allicin Alone and in Combination With Antifungal Drugs Against Microsporum canis Isolated From Patients With Tinea Capitis

Inhibitory effect of a combination of baicalein and quercetin flavonoids against Candida albicans strains isolated from the female reproductive system

Synergistic in vitro activity and mechanism of KBN lotion and miconazole nitrate against drug-resistant Candida albicans biofilms

In vitro susceptibility testing of the combination of terbinafine and itraconazole against dematiaceous fungi

Antifungal susceptibility of 30 clinical isolates of Rhodotorula spp. and literature review

Anti- Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole

Synergistic Antifungal Effect of Fluconazole Combined with Licofelone Against Resistant Candida Albicans